Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation

  • A. S. Kunin-Batson
  • E. G. ShapiroEmail author
  • K. D. Rudser
  • C. A. Lavery
  • K. J. Bjoraker
  • S. A. Jones
  • R. F. Wynn
  • A. Vellodi
  • J. Tolar
  • P. J. Orchard
  • J. E. Wraith
Research Report
Part of the JIMD Reports book series (JIMD, volume 29)


The long-term cognitive and functional outcomes of children with mucopolysaccharidosis type I (MPS-IH) post-hematopoietic cell transplant (HCT) are not well documented, and the role of genetic and treatment factors in these outcomes has yet to be defined. In this multi-site, international study, we (1) characterize the cognitive and functional status of 47 individuals (ages 2–25, mean of 10.6 years) with MPS-IH who are 1–24 years post HCT (mean = 9 years) and (2) examine contributions of genotype, transplant characteristics, and sociodemographic factors to cognitive ability, adaptive behavior, and quality of life. The overall cognitive ability of our sample was mildly impaired, more than two standard deviations below general population norms. Parent reported adaptive behaviors (i.e., communication, daily living, and motor skills) were similarly impaired with a relative strength in socialization. Quality of life, as reported by parents, fell more than two standard deviations below population norms for physical functioning; however, psychosocial quality of life (emotional well-being) approximated population norms. In linear regression analysis, adjusted for demographic and treatment factors, mutation severity was associated with lower cognitive ability (p = 0.005) and adaptive functioning (p = 0.004), but not parent ratings of children’s quality of life. Older age at HCT was associated with poorer physical quality of life (p = 0.002); lower socioeconomic status (p = 0.028) and unrelated bone marrow HCT (p = 0.010) were associated with poorer psychosocial quality of life. Implications for screening and early intervention for children at risk for poorer cognitive and functional outcomes are described.


Total Body Irradiation Mutation Type Hematopoietic Cell Transplantation Adaptive Functioning Adaptive Skill 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We would like to acknowledge the assistance of Edward Bendert, Jean Mercer, and Brianna Yund in the completion of this study and extend our gratitude to the families who participated in this research. This study was supported by The Society for Mucopolysaccharide Disease in the United Kingdom and in part by the National MPS Society, the United States (K. Bjoraker). Work on this study by Kyle Rudser was supported by UL1TR000114 from NCATS of NIH.


  1. Aldenhoven M, Boelens J, de Koning TJ (2008) The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant 14(5):485–498CrossRefPubMedGoogle Scholar
  2. Aldenhoven M, Wynn RF, Orchard PJ, O’Meara A, Veys P, Fischer A, Valayannopoulos V et al (2015) Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood 125(13):2164–2172CrossRefPubMedGoogle Scholar
  3. Bjoraker KJ, Delaney K, Peters C, Krivit W, Shapiro EG (2006) Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation. J Dev Behav Pediatr 27(4):290–296CrossRefPubMedGoogle Scholar
  4. Chen E, Martin AD, Matthews KA (2006) Understanding health disparities: the role of race and socioeconomic status in children’s health. Am J Public Health 96(4):702–708CrossRefPubMedPubMedCentralGoogle Scholar
  5. Clarke S, Eiser C, Skinner R (2008) Health-related quality of life in survivors of BMT for paediatric malignancy: a systematic review of the literature. Bone Marrow Transplant 42(2):73–82CrossRefPubMedGoogle Scholar
  6. Eisengart JB, Rudser KD, Tolar J et al (2013) Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome. J Pediatr 162(2):375–380.e371Google Scholar
  7. Grewal SS, Barker JN, Davies SM, Wagner JE (2003) Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 101(11):4233–4244CrossRefPubMedGoogle Scholar
  8. Griffiths R (1996) The Griffiths mental development scales. Association for Research in Infant and Child Development, the Test Agency, UKGoogle Scholar
  9. Guffon N, Bertrand Y, Forest I, Fouilhoux A, Froissart R (2009) Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years. J Pediatr 154(5):733–737CrossRefPubMedGoogle Scholar
  10. Hollingshead A (1957) Two factor index of social position. Hollingshead, New Haven. Available at
  11. Kunin‐Batson A, Kadan‐Lottick N, Neglia JP (2014) The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia. Psycho-Oncology 23(6):692–699CrossRefPubMedGoogle Scholar
  12. Landgraf JM, Abetz L, Ware JE (1996) Child Health Questionnaire (CHQ): a user’s manual. Health Institute, New England Medical Center, BostonGoogle Scholar
  13. Luiz D, Foxcroft C, Stewart R (2001) The construct validity of the Griffiths scales of mental development. Child Care Health Dev 27(1):73–83CrossRefPubMedGoogle Scholar
  14. Malm G, Gustafsson B, Berglund G et al (2008) Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT). Acta Paediatr 97(8):1108–1112CrossRefPubMedGoogle Scholar
  15. Matte U, Yogalingam G, Brooks D et al (2003) Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients. Mol Genet Metab 78(1):37–43CrossRefPubMedGoogle Scholar
  16. Muenzer J, Wraith JE, Clarke LA (2009) Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 123(1):19–29CrossRefPubMedGoogle Scholar
  17. Mullen EM (1995) Mullen scales of early learning. AGS, Circle PinesGoogle Scholar
  18. Pastores GM, Arn P, Beck M, Clarke JTR, Guffon N, Kaplan P, Muenzer J et al (2007) The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I. Mol Genet Metab 91(1):37–47CrossRefPubMedGoogle Scholar
  19. Peters C, Balthazor M, Shapiro EG et al (1996) Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87(11):4894–4902PubMedGoogle Scholar
  20. Peters C, Shapiro EG, Anderson J et al (1998) Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood 91(7):2601–2608PubMedGoogle Scholar
  21. Phipps S, Dunavant M, Lensing S, Rai S (2002) Acute health-related quality of life in children undergoing stem cell transplant: II. Medical and demographic determinants. Bone Marrow Transplant 29(5):435–442CrossRefPubMedGoogle Scholar
  22. Pinheiro J, Bates D, DebRoy S, Sarkar D, R Core Team (2014) nlme: linear and nonlinear mixed effects models. R package version 3.1Google Scholar
  23. Prasad VK, Kurtzberg J (2010) Transplant outcomes in mucopolysaccharidoses. Semin Hematol 47(1):59–69CrossRefPubMedGoogle Scholar
  24. Roid G (2003) Stanford-Binet intelligence scales, (SB5). Riverside, Rolling MeadowsGoogle Scholar
  25. Shapiro E, Lockman L, Balthazor M, Krivit W (1995) Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 18(4):413–429CrossRefPubMedGoogle Scholar
  26. Souillet G, Guffon N, Maire I et al (2003) Outcome of 27 patients with Hurler’s syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 31(12):1105–1117CrossRefPubMedGoogle Scholar
  27. Sparrow SS, Balla DA, Cicchetti DV (1984) Vineland adaptive behavior scales: interview edition, survey form manual. American Guidance Service, Circle PinesGoogle Scholar
  28. Sparrow S, Cicchetti D, Balla D (2005) Vineland adaptive behavior scales: (Vineland II), survey interview form/caregiver rating form. Pearson Assessments, LivoniaGoogle Scholar
  29. Terlato NJ, Cox GF (2003) Can mucopolysaccharidosis type I disease severity be predicted based on a patient’s genotype? A comprehensive review of the literature. Genet Med 5(4):286–294CrossRefPubMedGoogle Scholar
  30. Tolar J, Grewal S, Bjoraker K et al (2007) Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transplant 41(6):531–535CrossRefPubMedGoogle Scholar
  31. Vellodi A, Young E, Cooper A et al (1997) Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child 76(2):92–99CrossRefPubMedPubMedCentralGoogle Scholar
  32. Von Rueden U, Gosch A, Rajmil L, Bisegger C, Ravens-Sieberer U (2006) Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study. J Epidemiol Community Health 60(2):130–135CrossRefGoogle Scholar
  33. Wechsler D (1991) WISC-III: Wechsler intelligence scale for children. Psychological Corporation, San AntonioGoogle Scholar
  34. Wechsler D (1999) Wechsler abbreviated scale of intelligence. Psychological Corporation, San AntonioGoogle Scholar

Copyright information

© SSIEM and Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • A. S. Kunin-Batson
    • 1
    • 2
  • E. G. Shapiro
    • 2
    Email author
  • K. D. Rudser
    • 3
  • C. A. Lavery
    • 4
  • K. J. Bjoraker
    • 5
  • S. A. Jones
    • 6
  • R. F. Wynn
    • 6
  • A. Vellodi
    • 7
  • J. Tolar
    • 2
  • P. J. Orchard
    • 2
  • J. E. Wraith
    • 8
  1. 1.HealthPartners Institute for Education and ResearchMinneapolisUSA
  2. 2.Department of PediatricsUniversity of MinnesotaMinneapolisUSA
  3. 3.Division of BiostatisticsUniversity of MinnesotaMinneapolisUSA
  4. 4.Society for Mucopolysaccharide DiseaseBuckinghamshireUK
  5. 5.Neuropsychology ConsultantsMinneapolisUSA
  6. 6.Royal Manchester Children’s HospitalManchesterUK
  7. 7.Great Ormond Street HospitalLondonUK
  8. 8.Royal Manchester Children’s HospitalManchesterUK

Personalised recommendations